Shehnaaz Suliman
Director/Board Member at ULTRAGENYX PHARMACEUTICAL INC.
Net worth: 775 401 $ as of 30/04/2024
Shehnaaz Suliman active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Director/Board Member | 30/01/2019 | - |
| Independent Dir/Board Member | 30/01/2019 | - | |
| 10X GENOMICS, INC. | Director/Board Member | 01/08/2019 | - |
| Independent Dir/Board Member | 01/08/2019 | - | |
Executive Women in Bio
 Executive Women in Bio Miscellaneous Commercial ServicesCommercial Services Executive Women in Bio provides mentoring program services to support women in various stages of career and personal development. | Chairman | - | - |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Director/Board Member | 11/01/2022 | - |
| Chief Executive Officer | 11/01/2022 | - |
Career history of Shehnaaz Suliman
Former positions of Shehnaaz Suliman
| Companies | Position | Start | End |
|---|---|---|---|
| ALECTOR, INC. | Chief Executive Officer | 11/12/2019 | 15/12/2021 |
| Chief Operating Officer | 11/12/2019 | 01/01/2022 | |
| President | 11/12/2019 | 15/12/2021 | |
Parvus Therapeutics, Inc.
 Parvus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Parvus Therapeutics, Inc. manufactures and sells biopharmaceutical products. The private company is based in Calgary, Canada. | Director/Board Member | 01/10/2017 | 01/07/2019 |
| THERAVANCE BIOPHARMA, INC. | Corporate Officer/Principal | 01/07/2017 | 31/03/2019 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/06/2015 | 01/07/2017 |
Training of Shehnaaz Suliman
| Saïd Business School | Masters Business Admin |
| University of Oxford | Graduate Degree |
| University of Cape Town | Doctorate Degree |
Statistics
International
| United States | 7 |
| United Kingdom | 3 |
| South Africa | 2 |
Operational
| Director/Board Member | 4 |
| Corporate Officer/Principal | 2 |
| Masters Business Admin | 2 |
Sectoral
| Health Technology | 8 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 5 |
|---|---|
| THERAVANCE BIOPHARMA, INC. | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| ROCHE HOLDING AG | Health Technology |
| 10X GENOMICS, INC. | Health Technology |
| ALECTOR, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Parvus Therapeutics, Inc.
Parvus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Parvus Therapeutics, Inc. manufactures and sells biopharmaceutical products. The private company is based in Calgary, Canada. | Health Technology |
Executive Women in Bio
Executive Women in Bio Miscellaneous Commercial ServicesCommercial Services Executive Women in Bio provides mentoring program services to support women in various stages of career and personal development. | Commercial Services |
ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Health Technology |
- Stock Market
- Insiders
- Shehnaaz Suliman
- Experience
